|
MX2009010728A
(es)
*
|
2007-04-03 |
2009-10-26 |
Array Biopharma Inc |
Compuestos de imidazo[1,2-a]piridina como inhibidores de la tirosina-cinasa repectora.
|
|
CA2701516A1
(en)
|
2007-11-30 |
2009-06-04 |
Novartis Ag |
C2-c5-alkyl-imidazole-bisphosphonates
|
|
US8895550B2
(en)
|
2008-08-19 |
2014-11-25 |
Array Biopharma Inc. |
Triazolopyridine compounds as PIM kinase inhibitors
|
|
US8557809B2
(en)
|
2008-08-19 |
2013-10-15 |
Array Biopharma Inc. |
Triazolopyridine compounds as PIM kinase inhibitors
|
|
TWI496779B
(zh)
|
2008-08-19 |
2015-08-21 |
Array Biopharma Inc |
作為ｐｉｍ激酶抑制劑之三唑吡啶化合物
|
|
US8987251B2
(en)
|
2008-08-19 |
2015-03-24 |
Array Biopharma Inc. |
Triazolopyridine compounds as PIM kinase inhibitors
|
|
JP5781943B2
(ja)
|
2009-01-21 |
2015-09-24 |
ライジェル ファーマシューティカルズ， インコーポレイテッド |
炎症性疾患、自己免疫疾患または増殖性疾患の治療に有用なｎ２−（３−ピリジルまたはフェニル）−ｎ４−（４−ピペリジル）−２，４−ピリミジンジアミン誘導体
|
|
EP2438051A1
(en)
|
2009-06-05 |
2012-04-11 |
Pfizer Inc. |
L- ( piperidin-4-yl) -pyrazole derivatives as gpr 119 modulators
|
|
CA2778949C
(en)
|
2009-10-30 |
2018-02-27 |
Janssen Pharmaceutica Nv |
Imidazo[1,2-b]pyridazine derivatives and their use as pde10 inhibitors
|
|
EP2332917B1
(en)
*
|
2009-11-11 |
2012-08-01 |
Sygnis Bioscience GmbH & Co. KG |
Compounds for PIM kinase inhibition and for treating malignancy
|
|
FR2952934B1
(fr)
*
|
2009-11-23 |
2012-06-22 |
Sanofi Aventis |
Derives de pyridino-pyridinones, leur preparation et leur application en therapeutique
|
|
AR080754A1
(es)
|
2010-03-09 |
2012-05-09 |
Janssen Pharmaceutica Nv |
Derivados de imidazo (1,2-a) pirazina y su uso como inhibidores de pde10
|
|
ES2553635T3
(es)
|
2010-11-17 |
2015-12-10 |
Actelion Pharmaceuticals Ltd. |
Derivados de éster spiro[2.4]heptano puenteados
|
|
PH12013501754A1
(en)
|
2011-02-25 |
2013-10-14 |
Array Biopharma Inc |
Triazolopyridine compounds as pim kinase inhibitors
|
|
EP2524915A1
(en)
|
2011-05-20 |
2012-11-21 |
Sanofi |
2-Amino-3-(imidazol-2-yl)-pyridin-4-one derivatives and their use as VEGF receptor kinase inhibitors
|
|
JP6115962B2
(ja)
|
2011-06-27 |
2017-04-19 |
ヤンセン ファーマシューティカ エヌ．ベー． |
１−アリール−４−メチル−［１，２，４］トリアゾロ［４，３−ａ］キノキサリン誘導体
|
|
WO2013005057A1
(en)
|
2011-07-07 |
2013-01-10 |
Centro Nacional De Investigaciones Oncológicas (Cnio) |
New compounds
|
|
WO2013007768A1
(en)
|
2011-07-13 |
2013-01-17 |
F. Hoffmann-La Roche Ag |
Tricyclic heterocyclic compounds, compositions and methods of use thereof as jak inhibitors
|
|
AR089568A1
(es)
|
2011-10-14 |
2014-09-03 |
Ambit Biosciences Corp |
Compuestos heterociclicos y sus metodos de usos
|
|
MA37618B1
(fr)
|
2012-05-16 |
2017-08-31 |
Actelion Pharmaceuticals Ltd |
Dérivés pontés fluorés de spiro[2.4]heptane en tant qu'agonistes de récepteur alx
|
|
ES2855575T3
(es)
|
2012-06-26 |
2021-09-23 |
Janssen Pharmaceutica Nv |
Combinaciones que comprenden compuestos de 4-metil-[1,2,4]triazolo[4,3-a]quinoxalina como inhibidores de PDE2 e inhibidores de PDE10 para su uso en el tratamiento de trastornos neurológicos o metabólicos
|
|
MX362197B
(es)
|
2012-07-09 |
2019-01-08 |
Janssen Pharmaceutica Nv |
Derivados de imidazo[1,2-b]piridazina e imidazo[1,2-a]pirazina como inhibidores de la fosfodiesterasa 10; y el uso de los mismos en el tratamiento de trastornos neurológicos, psiquiátricos y metabólicos.
|
|
AU2013324396B2
(en)
|
2012-09-28 |
2018-10-04 |
Vanderbilt University |
Fused heterocyclic compounds as selective BMP inhibitors
|
|
US9278950B2
(en)
|
2013-01-14 |
2016-03-08 |
Incyte Corporation |
Bicyclic aromatic carboxamide compounds useful as Pim kinase inhibitors
|
|
AU2014207691B2
(en)
|
2013-01-15 |
2018-08-30 |
Incyte Holdings Corporation |
Thiazolecarboxamides and pyridinecarboxamide compounds useful as Pim kinase inhibitors
|
|
WO2015027124A1
(en)
|
2013-08-23 |
2015-02-26 |
Incyte Corporation |
Furo- and thieno-pyridine carboxamide compounds useful as pim kinase inhibitors
|
|
US9580418B2
(en)
|
2014-07-14 |
2017-02-28 |
Incyte Corporation |
Bicyclic aromatic carboxamide compounds useful as Pim kinase inhibitors
|
|
WO2016010897A1
(en)
|
2014-07-14 |
2016-01-21 |
Incyte Corporation |
Bicyclic heteroaromatic carboxamide compounds useful as pim kinase inhibitors
|
|
CN104597194B
(zh)
*
|
2015-01-15 |
2016-07-06 |
武汉轻工大学 |
3-氯-1，2-丙二醇的高效液相色谱-荧光检测方法
|
|
WO2016196244A1
(en)
|
2015-05-29 |
2016-12-08 |
Incyte Corporation |
Pyridineamine compounds useful as pim kinase inhibitors
|
|
AR105967A1
(es)
|
2015-09-09 |
2017-11-29 |
Incyte Corp |
Sales de un inhibidor de pim quinasa
|
|
WO2017059251A1
(en)
|
2015-10-02 |
2017-04-06 |
Incyte Corporation |
Heterocyclic compounds useful as pim kinase inhibitors
|
|
WO2019058393A1
(en)
|
2017-09-22 |
2019-03-28 |
Jubilant Biosys Limited |
HETEROCYCLIC COMPOUNDS AS INHIBITORS OF PAD
|
|
FI3697785T3
(fi)
|
2017-10-18 |
2023-04-03 |
Jubilant Epipad LLC |
Imidatsopyridiiniyhdisteitä pad:n estäjinä
|
|
JP7279057B6
(ja)
|
2017-11-06 |
2024-02-15 |
ジュビラント プローデル エルエルシー |
Ｐｄ１／ｐｄ－ｌ１活性化の阻害剤としてのピリミジン誘導体
|
|
WO2019102494A1
(en)
|
2017-11-24 |
2019-05-31 |
Jubilant Biosys Limited |
Heterocyclic compounds as prmt5 inhibitors
|
|
US10596161B2
(en)
|
2017-12-08 |
2020-03-24 |
Incyte Corporation |
Low dose combination therapy for treatment of myeloproliferative neoplasms
|
|
AU2019234185B2
(en)
|
2018-03-13 |
2024-08-01 |
Jubilant Prodel LLC. |
Bicyclic compounds as inhibitors of PD1/PD-L1 interaction/activation
|
|
EP3765460A1
(en)
|
2018-03-14 |
2021-01-20 |
Vanderbilt University |
Inhibition of bmp signaling, compounds, compositions and uses thereof
|
|
CN110833556A
(zh)
*
|
2018-08-15 |
2020-02-25 |
广西梧州制药（集团）股份有限公司 |
吡唑并嘧啶衍生物在治疗肝纤维化的用途
|
|
EP4660192A1
(en)
*
|
2020-08-05 |
2025-12-10 |
The General Hospital Corporation |
Salt inducible kinase inhibitors
|